Yu-Jin Kim

Dr. Yu-Jin Kim

The Scripps Research Institute (TSRI), La Jolla, CA, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Virology
Verified
Journal Article
Closed access
KKKi-Hye Kim
Ki-Hye Kim
YLYoung-Tae Lee
Young-Tae Lee
SPSoojin Park
Soojin Park
YJYu-Jin Jung
Yu-Jin Jung
YLYouri Lee
Youri Lee
SKSang-Moo Kang
Sang-Moo Kang

1 September 2018 in Viruses
Verified
Journal Article
Open access
PDF file
YWYe Wang
Ye Wang
YJYu-Jin Jung
Yu-Jin Jung
KKKi-Hye Kim
Ki-Hye Kim
YKYoungman Kwon
Youngman Kwon
YKYu-Jin Kim
Yu-Jin Kim
SKSang-Moo Kang
Sang-Moo Kang
Ginseng products used as herb nutritional supplements are orally consumed and fermented to ginsenoside compounds by the intestinal microbes. In this study, we investigated antiviral protective effects of fermented ginseng extracts against different strains of influenza viruses in genetically diverse mouse models. Intranasal coinoculation of mice with fermented ginseng extract and influenza virus improved survival rates and conferred protection against H1N1, H3N2, H5N1, and H7N9 strains, with the efficacy dependent on the dose of ginseng samples. Antiviral protection by fermented ginseng extract was observed in different genetic backgrounds of mice and in the deficient conditions of key adaptive immune components (CD4, CD8, B cell, MHCII). The mice that survived primary virus inoculation with fermented ginseng extract developed immunity against the secondary infection with homologous and heterosubtypic viruses. In vitro cell culture experiments showed moderate virus neutralizing activity by fermented ginseng extract, probably by inhibiting hemagglutination and neuraminidase activity. This study suggests that fermented ginseng extracts might provide a means to treat influenza disease regardless of virus strains.

1 October 2014 in Vaccine
Verified
Journal Article
Closed access
MKMin-Chul Kim
Min-Chul Kim
YLYu-Na Lee
Yu-Na Lee
HHHye Suk Hwang
Hye Suk Hwang
YLYoung-Tae Lee
Young-Tae Lee
EKEun-Ju Ko
Eun-Ju Ko
SKSang-Moo Kang
Sang-Moo Kang

1 August 2018 in Antiviral Research
Verified
Journal Article
Closed access
EKEun-Ju Ko
Eun-Ju Ko
YLYouri Lee
Youri Lee
YLYoung-Tae Lee
Young-Tae Lee
YKYu-Jin Kim
Yu-Jin Kim
KKKi-Hye Kim
Ki-Hye Kim
SKSang-Moo Kang
Sang-Moo Kang

1 September 2019 in Antiviral Research
Verified
Journal Article
Closed access
YKYu-Jin Kim
Yu-Jin Kim
BCBeatrice Cubitt
Beatrice Cubitt
ECEmily Chen
Emily Chen
MHMitchell V. Hull
Mitchell V. Hull
ACArnab K. Chatterjee
Arnab K. Chatterjee
Juan De La TorreJuan De La Torre
Juan De La Torre

15 October 2018 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
YKYu-Jin Kim
Yu-Jin Kim
KKKi-Hye Kim
Ki-Hye Kim
EKEun-Ju Ko
Eun-Ju Ko
MKMin-Chul Kim
Min-Chul Kim
YLYu-Na Lee
Yu-Na Lee
SKSang-Moo Kang
Sang-Moo Kang
Complement is the well-known innate immune defense system involved in the opsonization and lysis of pathogens but is less studied in establishing adaptive immunity after vaccination. Influenza virus HA-based vaccination confers protection via strain-specific neutralizing antibodies, whereas M2e-based vaccination induces a broad spectrum of protection by immunity against the conserved M2e epitopes. This study revealed the critical roles of C3 complement in inducing humoral and cellular immune responses after immunization with M2e or HA vaccines. C3 was found to be required for protection by M2e-based but not by HA-based active vaccination as well as for maintaining innate antigen-presenting cells. Findings in this study have insight into better understanding the roles of C3 complement in inducing effective innate and adaptive immunity as well as in conferring protection by cross-protective conserved M2e vaccination.